Switzerland· 50974002
Calcium-Acetat-Phosphatbinder Bichsel, Kapseln
A calcium acetate product, registered in Switzerland by Laboratorium Dr. G. Bichsel AG and dispensed under Swissmedic category B. The same ATC class is registered in 4 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Calcium acetate is registered in 4 of 19 countries.
Countries holding a registration under ATC V03AE07 (calcium acetate), each read from that country’s own register.
- This record: Switzerland
- 3 of them publish a price we can compare per daily dose
Calcium acetate · ATC V03AE07
4 / 19 countries
- Belgiumprice
- Finlandprice
- Netherlands
- Switzerlandprice
Price per daily dose
What a daily dose of calcium acetate costs, country by country.
Normalised to the WHO defined daily dose (6 g), so markets compare like for like.
- Switzerland: $2.13 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Calcium acetate · price per daily dose (6 g)
USD · FX 28 Sept 2026
- CH Switzerland$2.13
The record
At a glance
- Manufacturer
- Laboratorium Dr. G. Bichsel AG
- Country
- Switzerland (CH)
- ATC code
- V03AE07
- ATC class
- Calcium acetate
- Defined daily dose
- 6 g, O
- Swissmedic category
- B
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
81 interactions on record for calcium acetate.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Calcium acetate · interactions on record
81 records
- 4 severe
- 77 moderate
Most severe, free to view
- DolutegravirJ05AJ03severe
- DolutegravirJ05AX12severe
- ErdafitinibL01EN01severe
- ErdafitinibL01EX16severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under V03AE07
Calcium acetate, as other registers publish it.
- SwitzerlandCalcium Ac Phosphatb Bichsel
- SwitzerlandCalcium Ac Phosphatb Bichsel
- SwitzerlandCalcium-Acetat Salmon Pharma 500 mg, FilmtablettenSalmon Pharma GmbH
- SwitzerlandCalcium-Acetat Salmon Pharma 500 mg, FilmtablettenSalmon Pharma GmbH
- NetherlandsCalciumacetaat-Nefro 500 mg, filmomhulde tablettenMedice Arzneimittel Pütter GmbH & Co. KG
- NetherlandsCalciumacetaat-Nefro 700 mg, filmomhulde tablettenMedice Arzneimittel Pütter GmbH & Co. KG
- FinlandPhos-ExMedans Oy
- BelgiumPhoslo 667 mgFresenius Medical Care Deutschland
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2d4d3737-1cb8-4b04-ab84-a044b5386d9e GET /v1/drugs/2d4d3737-1cb8-4b04-ab84-a044b5386d9e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about calcium acetate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.